BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 11355072)

  • 1. Persistent pulmonary hypertension of the newborn: experience in a single institution.
    Hsieh WS; Yang PH; Fu RH
    Acta Paediatr Taiwan; 2001; 42(2):94-100. PubMed ID: 11355072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endotracheal tolazoline administration in neonates with persistent pulmonary hypertension.
    Parida SK; Baker S; Kuhn R; Desai N; Pauly TH
    J Perinatol; 1997; 17(6):461-4. PubMed ID: 9447533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent pulmonary hypertension in high-risk congenital diaphragmatic hernia patients: incidence and vasodilator therapy.
    Bos AP; Tibboel D; Koot VC; Hazebroek FW; Molenaar JC
    J Pediatr Surg; 1993 Nov; 28(11):1463-5. PubMed ID: 8301459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasodilators in persistent pulmonary hypertension of the newborn: a need for optimal appraisal of efficacy.
    Gouyon JB; Françoise M
    Dev Pharmacol Ther; 1992; 19(2-3):62-8. PubMed ID: 1340438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-hyperventilation respiratory therapy of persistent pulmonary hypertension of the newborn.
    Hsieh WS; Hwang MS; Su WJ
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(1):24-9. PubMed ID: 7778441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine infusion improves oxygenation in term infants with respiratory failure.
    Konduri GG; Garcia DC; Kazzi NJ; Shankaran S
    Pediatrics; 1996 Mar; 97(3):295-300. PubMed ID: 8604260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The prevalence and characteristics of persistent pulmonary hypertension of the newborn. A multicenter study. The Study Group of the Società Italiana di Cardiologia Pediatrica (SICP)].
    Favilli S; De Simone L; Pollini I; Bettuzzi MG; Cianfrini D; Crepaz R; Santillo V; Trevisanuto D; Vignati G; Manetti A
    G Ital Cardiol; 1998 Nov; 28(11):1247-52. PubMed ID: 9866802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iloprost inhalation for the treatment of severe persistent pulmonary hypertension of the newborn, experience at QSNICH.
    Chotigeat U; Champrasert M; Khorana M; Sangtaweesin V; Kanjanapattanakul W
    J Med Assoc Thai; 2014 Jun; 97 Suppl 6():S89-94. PubMed ID: 25391178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent pulmonary hypertension of the newborn successfully treated with beraprost sodium: a retrospective chart review.
    Nakwan N; Nakwan N; Wannaro J
    Neonatology; 2011; 99(1):32-7. PubMed ID: 20588068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on PPHN: mechanisms and treatment.
    Nair J; Lakshminrusimha S
    Semin Perinatol; 2014 Mar; 38(2):78-91. PubMed ID: 24580763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of persistent pulmonary hypertension of the newborn: impact of the perinatal environment.
    Storme L; Aubry E; Rakza T; Houeijeh A; Debarge V; Tourneux P; Deruelle P; Pennaforte T;
    Arch Cardiovasc Dis; 2013 Mar; 106(3):169-77. PubMed ID: 23582679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of oral sildenafil in neonatal persistent pulmonary hypertension of non-cardiac causes.
    Sayed A; Bisheer N
    J Neonatal Perinatal Med; 2015; 8(3):215-20. PubMed ID: 26485555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical response to inhaled nitric oxide in persistent pulmonary hypertension of the newborn.
    Ko SY; Chang YS; Park WS
    J Korean Med Sci; 1998 Oct; 13(5):500-6. PubMed ID: 9811179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sildenafil as “first line therapy” in pulmonary persistent hypertension of the newborn?
    Nassi N; Daniotti M; Agostiniani S; Lombardi E; Favilli S; Donzelli GP
    J Matern Fetal Neonatal Med; 2010 Oct; 23 Suppl 3():104-5. PubMed ID: 20836736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostacyclin treatment for persistent pulmonary hypertension of the newborn.
    Eronen M; Pohjavuori M; Andersson S; Pesonen E; Raivio KO
    Pediatr Cardiol; 1997; 18(1):3-7. PubMed ID: 8960484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors of meconium aspiration syndrome developing into persistent pulmonary hypertension of newborn.
    Hsieh TK; Su BH; Chen AC; Lin TW; Tsai CH; Lin HC
    Acta Paediatr Taiwan; 2004; 45(4):203-7. PubMed ID: 15624365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting the response to inhaled nitric oxide therapy in persistent pulmonary hypertension of the newborn infants.
    Hwang SJ; Lee KH; Hwang JH; Choi CW; Shim JW; Chang YS; Park WS
    Yonsei Med J; 2004 Feb; 45(1):49-55. PubMed ID: 15004868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary dysfunction and therapeutic hypothermia in asphyxiated newborns: whole body versus selective head cooling.
    Sarkar S; Barks JD; Bhagat I; Dechert R; Donn SM
    Am J Perinatol; 2009 Apr; 26(4):265-70. PubMed ID: 19021092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn.
    Reynolds EW; Ellington JG; Vranicar M; Bada HS
    Pediatrics; 2004 Nov; 114(5):1297-304. PubMed ID: 15520111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved oxygenation in a randomized trial of inhaled nitric oxide for persistent pulmonary hypertension of the newborn.
    Wessel DL; Adatia I; Van Marter LJ; Thompson JE; Kane JW; Stark AR; Kourembanas S
    Pediatrics; 1997 Nov; 100(5):E7. PubMed ID: 9347001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.